Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 7.300
- +0.110+1.53%
Close Feb 28 16:00 ET
- 7.300
- 0.0000.00%
Post 20:01 ET
448.81MMarket Cap-1.11P/E (TTM)
7.320High7.070Low1.85MVolume7.190Open7.190Pre Close13.42MTurnover3.41%Turnover RatioLossP/E (Static)61.48MShares22.34052wk High0.96P/B395.85MFloat Cap4.62052wk Low--Dividend TTM54.23MShs Float195.970Historical High--Div YieldTTM3.48%Amplitude4.620Historical Low7.259Avg Price1Lot Size
About Sage Therapeutics Company
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees353
Fiscal Year Ends12-31
Address55 Cambridge Parkway
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com
Company Executives
- Name
- Position
- Salary
- Barry E. Greene
- Director, President and Chief Executive Officer
- 6.24M
- Christopher Benecchi
- Chief Operating Officer, Treasurer, Principal Financial and Accounting Officer
- 2.28M
- Laura Gault, M.D.,PhD
- Chief Medical Officer
- 1.27M
- Jessica J. Federer
- Independent Director
- 962.23K
- Dr. George S. Golumbeski, PhD
- Independent Director
- 412.55K
- Elizabeth Barrett
- Independent Director
- 425.05K
- James M. Frates
- Independent Director
- 435.05K
- Geno J. Germano
- Independent Director
- 417.55K
- Dr. Steven M. Paul, M.D.
- Independent Director
- 420.05K
- Michael F. Cola
- Independent Director
- 440.05K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.